| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.35 | 0.1 |